Assessing mobility and fall risks in older adults with mild cognitive impairment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on older adults diagnosed with mild cognitive impairment (MCI) to identify specific predictors for falls. It aims to assess gait disorders and the risk of falls in this vulnerable population, as both cognitive and physical impairments can significantly impact their independence. By understanding these predictive factors, the study seeks to inform personalized prevention strategies to mitigate the risk of falls and subsequent cognitive decline. Participants must be able to walk a short distance and comprehend French for neuropsychological assessments.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient being diagnosed with MCI, according to the 2011 criteria
* Able to walk 4 meters with or without technical assistance
* Comprehension of French language allowing the realization of the neuropsychological assessment

Exclusion Criteria:

* Severe visual or hearing impairment that does not allow the assessment
* Severe pathology that makes follow-up impossible
* Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of social security insurance, refusal to sign consent form
* Under legal protection (guardianship, curatorship, safeguard of justice)

Where it's running

• Les Bateliers Chu Lille
  Lille, France Recruiting
• Hop Salengro - Hopital B
  Lille, France Recruiting

Study contacts

• Principal investigator: Yaohua CHEN, MD — University Hospital, Lille
• Study coordinator: Yaohua CHEN, MD
• Email: Yaohua.chen@chru-lille.fr
• Phone: 0320445962

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• New flutemetamol F18 formulation to see if it works as well as current for brain amyloid imaging

  Researchers are testing a new flutemetamol F18 formulation (GE-287) to see if it identifies brain amyloid as accurately as the current formulation in people 50 and older who are undergoing amyloid PET scans for cognitive decline.

  Recruiting at 5 sites Phase 2 GE Healthcare · Aventura, Florida and 5 other locations · NCT07873463

• Longevity Metrics AI/ML Development Study

  Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.

  Recruiting Longevity Metrics, Inc. · Boulder, Colorado · NCT07808619

• Immersive nature-based wellbeing program for older adults with cognitive impairment

  A nature-inspired immersive virtual reality program is being tested to see if it can improve well-being and daily function for older adults with mild to moderate cognitive impairment.

  Recruiting Consorci Sanitari de Terrassa · Terrassa, Barcelona · NCT07802392

• Hesperidin for better thinking in overweight older adults

  In adults aged 55–75 who are overweight, taking hesperidin or a placebo for 10 weeks will show whether the citrus flavonoid can improve thinking skills like memory, attention, and problem-solving.

  Recruiting University of Glasgow · Shanghai, Shanghai Municipality · NCT07750223

• Structured Receptive Music to Help with Care During Bathing for People with Dementia

  A structured daily music program used during hygiene care is being tested to see if it reduces refusals of care by residents with dementia in French nursing homes.

  Recruiting at 6 sites Lna Sante · Amiens and 11 other locations · NCT07730957

• Risk of delirium and cognitive problems after TUR-P in older adults

  This study tests whether certain perioperative factors can predict delirium and postoperative cognitive dysfunction in people aged 65 and older undergoing transurethral resection.

  Recruiting Muğla Sıtkı Koçman University · Muğla · NCT07719712

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.